Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study

Authors
Category Primary study
JournalActa myologica
Year 2023
This article has no abstract
Epistemonikos ID: abd3783d9c5579babd8b57a2807a0cc894b2723d
First added on: Nov 03, 2023